141 related articles for article (PubMed ID: 8675521)
1. Modified Blalock-Taussig shunt: statistical analysis of potential factors influencing shunt outcome.
Tsai KT; Chang CH; Lin PJ
J Cardiovasc Surg (Torino); 1996 Apr; 37(2):149-52. PubMed ID: 8675521
[TBL] [Abstract][Full Text] [Related]
2. Systemic-pulmonary shunts in infants and children. Early and late results.
Lamberti JJ; Carlisle J; Waldman JD; Lodge FA; Kirkpatrick SE; George L; Mathewson JW; Turner SW; Pappelbaum SJ
J Thorac Cardiovasc Surg; 1984 Jul; 88(1):76-81. PubMed ID: 6204171
[TBL] [Abstract][Full Text] [Related]
3. Systemic-pulmonary polytetrafluoroethylene shunts in palliative operations for congenital heart disease. Revival of the central shunt.
Amato JJ; Marbey ML; Bush C; Galdieri RJ; Cotroneo JV; Bushong J
J Thorac Cardiovasc Surg; 1988 Jan; 95(1):62-9. PubMed ID: 2447447
[TBL] [Abstract][Full Text] [Related]
4. [Long-term patency after the Blalock-Taussig operation--comparison between classic and modified shunts].
Ohuchi H; Okabe H; Nagata N; Koseni K; Kaneko Y; Itoh K
Nihon Kyobu Geka Gakkai Zasshi; 1996 Aug; 44(8):1108-13. PubMed ID: 8828367
[TBL] [Abstract][Full Text] [Related]
5. The modified blalock-taussig shunt using microporous expanded polytetrafluoroethylene (PTFE).
Lawless CE; Smith EE; Hallidie-Smith K; Sapsford RN
J Cardiovasc Surg (Torino); 1982; 23(4):287-92. PubMed ID: 7107686
[TBL] [Abstract][Full Text] [Related]
6. Blalock-Taussig shunts and modified Blalock-Taussig shunts.
Sanchez HE; Vosloo S
S Afr Med J; 1985 Feb; 67(5):168-70. PubMed ID: 3983755
[TBL] [Abstract][Full Text] [Related]
7. Color Doppler imaging of modified Blalock-Taussig shunts during infancy.
Hofbeck M; Singer H; Wild F; vd Emde J
Pediatr Cardiol; 1994; 15(4):163-6. PubMed ID: 7527527
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of systemic to pulmonary artery shunts in patients weighing less than 3 kg: analysis of shunt type, size, and surgical approach.
Myers JW; Ghanayem NS; Cao Y; Simpson P; Trapp K; Mitchell ME; Tweddell JS; Woods RK
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):672-7. PubMed ID: 24252942
[TBL] [Abstract][Full Text] [Related]
9. A comparison of Blalock-Taussig, Waterston, and polytetrafluoroethylene shunts in children less than two weeks of age.
Woolf PK; Stephenson LW; Meijboom E; Bavinck JH; Gardner TJ; Donahoo JS; Edie RN; Edmunds LH
Ann Thorac Surg; 1984 Jul; 38(1):26-30. PubMed ID: 6203495
[TBL] [Abstract][Full Text] [Related]
10. Operative outcome and intermediate term follow-up of neonatal Blalock-Taussig shunts.
Sivakumar K; Shivaprakasha K; Rao SG; Kumar RK
Indian Heart J; 2001; 53(1):66-70. PubMed ID: 11456144
[TBL] [Abstract][Full Text] [Related]
11. Color Doppler imaging of modified Blalock-Taussig shunts during infancy.
Hofbeck M; Singer H; Wild F; vd Emde J
Pediatr Cardiol; 1994; 15(6):163-6. PubMed ID: 7530844
[TBL] [Abstract][Full Text] [Related]
12. Classic Blalock-Taussig shunt in neonates.
Yoshimura N; Yamaguchi M; Ohashi H; Oshima Y; Toyoda Y; Ogawa K
J Cardiovasc Surg (Torino); 1999 Feb; 40(1):107-10. PubMed ID: 10221395
[TBL] [Abstract][Full Text] [Related]
13. Experience with the modified Blalock-Taussig operation using polytetrafluoroethylene (Impra) grafts.
Kay PH; Capuani A; Franks R; Lincoln C
Br Heart J; 1983 Apr; 49(4):359-63. PubMed ID: 6830670
[TBL] [Abstract][Full Text] [Related]
14. Cryopreserved Saphenous Vein Compared With PTFE Graft for Use as Modified Blalock-Taussig or Central Shunt in Cyanotic Congenital Heart Disease.
Kaur R; Bhurtel D; Bielefeld MR; Morales JM; Durham LA
World J Pediatr Congenit Heart Surg; 2018 Sep; 9(5):509-512. PubMed ID: 30157727
[TBL] [Abstract][Full Text] [Related]
15. Modified Blalock-Taussig shunts: results in infants less than 3 months of age.
Tamisier D; Vouhé PR; Vernant F; Lecá F; Massot C; Neveux JY
Ann Thorac Surg; 1990 May; 49(5):797-801. PubMed ID: 1692681
[TBL] [Abstract][Full Text] [Related]
16. Optimal Graft Size of Modified Blalock-Taussig Shunt for Biventricular Circulation in Neonates and Small Infants.
Shibata M; Itatani K; Oka N; Yoshii T; Nakamura Y; Kitamura T; Horai T; Miyaji K
Int Heart J; 2015; 56(5):533-6. PubMed ID: 26370364
[TBL] [Abstract][Full Text] [Related]
17. Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts.
de Leval MR; McKay R; Jones M; Stark J; Macartney FJ
J Thorac Cardiovasc Surg; 1981 Jan; 81(1):112-9. PubMed ID: 6450303
[TBL] [Abstract][Full Text] [Related]
18. Bovine mesenteric venous graft as an alternative conduit in patients with cyanotic heart disease with e-polytetrafluoroethylene graft failure caused by thrombophilic factor positivity after modified Blalock-Taussig shunt.
Akbulut B; Dogan OF; Guvener M; Yilmaz M; Yorgancioglu C; Karagoz T; Ozkutlu S; Demircin M; Dogan R
Heart Surg Forum; 2008; 11(1):E37-41. PubMed ID: 18270138
[TBL] [Abstract][Full Text] [Related]
19. Modified Blalock-Taussig shunt versus ductal stenting for palliation of cardiac lesions with inadequate pulmonary blood flow.
McMullan DM; Permut LC; Jones TK; Johnston TA; Rubio AE
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):397-401. PubMed ID: 24071469
[TBL] [Abstract][Full Text] [Related]
20. Neonatal Blalock-Taussig shunt: technical aspects and postoperative management.
Swain SK; Dharmapuram AK; Reddy P; Ramdoss N; Raghavan SS; Kona SM
Asian Cardiovasc Thorac Ann; 2008 Jan; 16(1):7-10. PubMed ID: 18245697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
